News

Blood levels of Posiphen associated with this study were higher than those associated with beneficial effects on beta-amyloid metabolism in animal models. The build-up of beta-amyloid is generally

Additional findings from the trial showed that serum 8-hydroxy-2′- deoxyguanosine (serum 8OH2’dG) levels, which are markedly elevated in Huntington’s disease patients, were reduced for patients receiving HD-02. Some

The study employs a new formulation of Genasense that is five-fold more concentrated than material currently used in clinical trials. Having completed requisite animal toxicology work, the trial

The collaboration will use Caprion’s CellCarta proteomics platform, which profiles the expression and identity of proteins detected in tissues and blood plasma, to support the discovery of biomarkers.

Revenue for the company was up by 66% with $44.5 million coming in to the company in 2005 compared with $26.8 million reported in 2004. “Crucell has stepped

By 2010 Amgen expects to employ more than 1,100 people at its new Irish facility, which will produce products for patients in Europe and other parts of the

The company is testing Hylenex, a liquid injectable formulation that includes the active pharmaceutical ingredient recombinant human hyaluronidase (rHuPH20). Hylenex was approved by the FDA for use as

The proposed trial will compare the safety and efficacy of APF530 with MGI Pharma’s Aloxi (palonosetron) for the treatment of acute and delayed chemotherapy-induced nausea and vomiting (CINV)

The investigation included 86 autopsied subjects from the aptly named “Religious Orders Study”. Participants in the study were older Catholic clergy who enrolled without known dementia and agreed